🇺🇸 FDA
Pipeline program

FGI-101-1A6

FGI-101-CP002

Phase 1 small_molecule active

Quick answer

FGI-101-1A6 for Influenza is a Phase 1 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Influenza
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials